99.9% Local Anesthetic Levobup

99.9% Local Anesthetic Levobupivacaine HCl Powder / Levobupivacaine Hydrochloride 1.Quick Detail: Levobupivacaine hydrochloride Cas:*-48-2 Mf:C18h29cln2o Mw:324.89 Product categories:Pharmaceutical raw materials;Active pharmaceutical ingredients Chemical properties:White crystalline powder Usage:Anesthetic;Na+ channel inhibitor. Packaging details: 25kg/drum,1kg/foil bag Delivery time: 1-2 days Payment terms: t/t, western union, money gram 2.Description: Levobupivacaine (rINN) is a local anaesthetic drug belonging to the amino amide group. It is the S-enantiomer of bupivacaine. The hydrochloride salt of levobupivacaine, an amide derivative with anesthetic property. Levobupivacaine reversibly binds voltage-gated sodium channels to modulate ionic flux and prevent the initiation and transmission of nerve impulses (stabilizing neuronal membrane), thereby resulting in analgesia and anesthesia. In comparison with racemic bupivacaine, levobupivacaine is associated with less vasodilation and has a longer duration of action. 3.Applications: Levobupivacaine is the S-enantiomer of bupivacaine hydrochloride and is chemically described as (S)-1-butyl-2-piperidylformo-2', 6'-xylidide hydrochloride. Levobupivacaine is a member of the amino amide class of local anaesthetics. It is indicated for surgical anesthesia and postoperative pain management.

Please Note that this information was issued on BestB2B.com!

Insulation Panel,roof panels2024-01-29

EPS sandwich panel2024-01-29

Insulated Metal Panels Increas2024-01-29

Insulated Metal Roof Panel2024-01-29

Light Insulated Metal Wall Pa2024-01-29

Insulated Metal Wall Panels2024-01-29

Insulated sandwich panels / In2024-01-29

Trapezoidal Roof Panel / Wall2024-01-29

100G QSFP28 SWDM4 100m LC Opti2024-02-01

100G QSFP28 SR4 100M MPO Optic2024-02-01

200G QSFP56 SR4 100m MPO Optic2024-02-01

400G OSFP SR8 100m MPO Optical2024-02-01

400G QSFP-DD LR8 10KM LC Optic2024-02-01

400G QSFP-DD LR4 10KM LC Media2024-02-01

400G QSFP-DD 4x100G LR 10KM 2024-01-29